At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02179 RECBIO-B
Closed 08-29 15:31:01
7.740
-0.140
-1.78%
High7.740
Low7.740
Vol1.00K
Open7.740
D1 Closing7.880
Amplitude0.00%
Mkt Cap3.74B
Tradable Cap2.45B
Total Shares482.96M
T/O7.74K
T/O Rate0.00%
Tradable Shares316.14M
P/B6.46
ROE-70.23%
EPS-1.27
52wk High9.800
52wk Low6.760
P/E-6.07
Dividend0.00
Div.Yield0.00
ROA-17.32%
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
RECBIO-B (02179) Reports Interim Results with Shareholders' Attributable Loss of 341 Million Yuan, Up 36.7% Year-on-Year
Jiangsu Recbio Technology Co. Ltd. Board Meeting: Participation in H Share Full Circulation Plan and Election of Ms. Chen Qingqing to Nomination Committee
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.